These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 1359169)
1. [Varicella-zoster virus infection after peripheral blood stem cell autografts in children with leukemia or non-Hodgkin's lymphoma]. Okamoto Y; Takaue Y; Saito S; Hirao A; Suzue T; Shimizu T; Abe T; Sato J; Watanabe T; Kawano Y Rinsho Ketsueki; 1992 Sep; 33(9):1204-9. PubMed ID: 1359169 [TBL] [Abstract][Full Text] [Related]
2. Regeneration of immunity and varicella-zoster virus infection after high-dose chemotherapy and peripheral blood stem cell autografts in children. Takaue Y; Okamoto Y; Kawano Y; Suzue T; Abe T; Saito SI; Sato J; Hirao A; Makimoto A; Kawahito M Bone Marrow Transplant; 1994 Aug; 14(2):219-23. PubMed ID: 7994235 [TBL] [Abstract][Full Text] [Related]
3. Autologous peripheral blood stem cell transplantation in children with non-Hodgkin's lymphoma: A report from the Korean society of pediatric hematology-oncology. Won SC; Han JW; Kwon SY; Shin HY; Ahn HS; Hwang TJ; Yang WI; Lyu CJ Ann Hematol; 2006 Nov; 85(11):787-94. PubMed ID: 16932891 [TBL] [Abstract][Full Text] [Related]
4. Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders. Kim DH; Messner H; Minden M; Gupta V; Kuruvilla J; Wright J; Lipton J Transpl Infect Dis; 2008 Apr; 10(2):90-8. PubMed ID: 17605742 [TBL] [Abstract][Full Text] [Related]
5. [Peripheral blood stem cell autografts (PBSCT) in the treatment of 30 children with acute leukemias and lymphoma]. Abe T; Takaue Y; Matsunaga K; Saito S; Hirao A; Okamoto Y; Nakanishi J; Watanabe T; Kawano Y; Ninomiya T Rinsho Ketsueki; 1991 Nov; 32(11):1425-32. PubMed ID: 1758049 [TBL] [Abstract][Full Text] [Related]
6. Long-term acyclovir prophylaxis for prevention of varicella zoster virus infection after autologous blood stem cell transplantation in patients with acute leukemia. Sempere A; Sanz GF; Senent L; de la Rubia J; Jarque I; López F; Arilla MJ; Guinot M; Martín G; Martínez J Bone Marrow Transplant; 1992 Dec; 10(6):495-8. PubMed ID: 1362686 [TBL] [Abstract][Full Text] [Related]
7. Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group. Onozawa M; Hashino S; Haseyama Y; Hirayama Y; Iizuka S; Ishida T; Kaneda M; Kobayashi H; Kobayashi R; Koda K; Kurosawa M; Masauji N; Matsunaga T; Mori A; Mukai M; Nishio M; Noto S; Ota S; Sakai H; Suzuki N; Takahashi T; Tanaka J; Torimoto Y; Yoshida M; Fukuhara T Biol Blood Marrow Transplant; 2009 Jun; 15(6):724-9. PubMed ID: 19450757 [TBL] [Abstract][Full Text] [Related]
8. [Autologous bone marrow transplantation in children with acute leukemia or non-Hodgkin's lymphoma]. Emminger W; Hinterberger W; Emminger-Schmidmeier W; Peters C; Fink FM; Zoubek A; Haas OA; Höcker P; Hawliczek R; Knapp W Wien Med Wochenschr; 1991; 141(9-10):225-8. PubMed ID: 1683071 [TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of prophylactic strategy of long-term low-dose acyclovir for Varicella-Zoster virus infection after allogeneic peripheral blood stem cell transplantation. Kim DH; Kumar D; Messner HA; Minden M; Gupta V; Kuruvilla J; Chae YS; Sohn SK; Lipton JH Clin Transplant; 2008; 22(6):770-9. PubMed ID: 18707605 [TBL] [Abstract][Full Text] [Related]
10. Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma. Stockerl-Goldstein KE; Horning SJ; Negrin RS; Chao NJ; Hu WW; Long GD; Hoppe RT; Amylon MD; Brown BW; Wong RM; Blume KG Biol Blood Marrow Transplant; 1996 May; 2(2):76-85. PubMed ID: 9118302 [TBL] [Abstract][Full Text] [Related]
11. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas]. Wójcik B; Kowalczyk JR; Chybicka A; Wachowiak J; Drabko K; Zaucha-Prazmo A; Choma M; Gorczyńska E; Toporski J; Turkiewicz D; Kałwak K; Pieczonka A; Boruczkowski D Przegl Lek; 2004; 61 Suppl 2():53-6. PubMed ID: 15686047 [TBL] [Abstract][Full Text] [Related]
12. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Bierman PJ; Sweetenham JW; Loberiza FR; Taghipour G; Lazarus HM; Rizzo JD; Schmitz N; van Besien K; Vose JM; Horowitz M; Goldstone A; J Clin Oncol; 2003 Oct; 21(20):3744-53. PubMed ID: 12963703 [TBL] [Abstract][Full Text] [Related]
13. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation. Leung TF; Chik KW; Li CK; Lai H; Shing MM; Chan PK; Lee V; Yuen PM Bone Marrow Transplant; 2000 Jan; 25(2):167-72. PubMed ID: 10673675 [TBL] [Abstract][Full Text] [Related]
14. Effects of rhG-CSF (filgrastim) on the recovery of hematopoiesis after high-dose chemotherapy and autologous peripheral blood stem cell transplantation in children: a report from the Children's Cancer and Leukemia Study Group of Japan. Suzue T; Takaue Y; Watanabe A; Kawano Y; Watanabe T; Abe T; Kuroda Y; Matsushita T; Kikuta A; Iwai A Exp Hematol; 1994 Nov; 22(12):1197-202. PubMed ID: 7523170 [TBL] [Abstract][Full Text] [Related]
15. [A multicenter early phase II study of high-dose chemotherapy with autologous peripheral blood stem cell transplantation for treatment of intermediate-grade non-Hodgkin's lymphoma. Japan Blood Cell Transplantation Study Group]. Chou T; Ishiguro T; Imajo K; Kawano F; Gondo H; Kasai M; Masuda M; Koike M; Shimazaki C; Hara M; Shinagawa K; Ogawa M; Takaku F; Harada M Rinsho Ketsueki; 1999 Oct; 40(10):1058-67. PubMed ID: 10565222 [TBL] [Abstract][Full Text] [Related]
16. A phase II multicenter trial of high-dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for patients with high-risk non-Hodgkin's lymphoma. Schenkein DP; Roitman D; Miller KB; Morelli J; Stadtmauer E; Pecora AL; Cassileth P; Fernandez H; Cooper BW; Kutteh L; Lazarus HM Biol Blood Marrow Transplant; 1997 Oct; 3(4):210-6. PubMed ID: 9360783 [TBL] [Abstract][Full Text] [Related]
17. Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation. Sobecks RM; Le Beau MM; Anastasi J; Williams SF Bone Marrow Transplant; 1999 Jun; 23(11):1161-5. PubMed ID: 10382956 [TBL] [Abstract][Full Text] [Related]
18. [High dose chemoradiotherapy with autologous hemotopoietic stem cell transplantation for treatment of patients with advanced Hodgkin's lymphoma: a report of 11 cases]. Zhou SY; Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou AP; Feng FY Ai Zheng; 2002 Apr; 21(4):405-8. PubMed ID: 12452021 [TBL] [Abstract][Full Text] [Related]
19. High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease. Schiffman K; Buckner CD; Maziarz R; Maloney DG; Appelbaum FR; Press O; Gooley T; Holmberg L; Lilleby K; Clift R; Zuckerman N; Klarnet J; Weaver C; Chauncey T; Bensinger WI Biol Blood Marrow Transplant; 1997 Nov; 3(5):261-6. PubMed ID: 9450921 [TBL] [Abstract][Full Text] [Related]
20. [Combined high dose chemotherapy with autologous stem cell transplantation and total body radiotherapy for 32 malignant lymphoma patients]. Wang H; Cui X; Shao Y Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):436-8. PubMed ID: 11810783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]